Skip to main content
. 2014 Oct 14;124(25):3817–3827. doi: 10.1182/blood-2014-07-587477

Figure 2.

Figure 2

Survival outcomes. Kaplan-Meier estimates of DFS and OS are shown for the entire cohort by (A-B) disease type and (C-D) donor type. Kaplan-Meier estimates of the composite outcome of cGVHD-DFS are shown for the entire cohort (E) by disease type and (F) for AML patients by remission status at the time of allogeneic transplantation. Pts, patients.